Advanced Health Intelligence ( ) - 株価, ニュースと分析ASX:AHI

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

AHI 株式概要

Operates as a mobile application and technology development company in Australia and internationally.

AHI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	5/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

報酬

収益は年間178.92%増加すると予測されています

リスク分析

収益が 100 万ドル未満 ( A$-925K )

株式の流動性は非常に低い

マイナスの株主資本

過去1年間で株主の希薄化が進んだ

+1 さらなるリスク

Advanced Health Intelligence Ltd 競合他社

BlinkLab

ASX:BB1

AU$25.3m

Enlitic

ASX:ENL

AU$18.6m

Artrya

ASX:AYA

AU$18.9m

TrivarX

ASX:TRI

AU$10.7m

価格と性能

Summary of all time highs, changes and price drops for Advanced Health Intelligence
Historical stock prices
Current Share Price	AU$0.092
52 Week High	AU$0.40
52 Week Low	AU$0.07
Beta	1.46
1 Month Change	0%
3 Month Change	8.24%
1 Year Change	15.00%
3 Year Change	-94.68%
5 Year Change	-64.62%
Change since IPO	-34.29%

Recent updates

株主還元

	AHI	AU Healthcare Services	AU 市場
7D	0%	4.9%	-2.0%
1Y	15.0%	77.7%	6.1%

業界別リターン: AHI過去 1 年間で82.2 % の収益を上げたAustralian Healthcare Services業界を下回りました。

リターン対市場: AHI過去 1 年間で8.2 % の収益を上げたAustralian市場を上回りました。

価格変動

Is AHI's price volatile compared to industry and market?
AHI volatility
AHI Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	9.4%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	16.1%
10% least volatile stocks in AU Market	3.2%

安定した株価: AHI過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: 過去 1 年間のAHIのボラティリティの変化を判断するにはデータが不十分です。

会社概要

設立	従業員	CEO（最高経営責任者	ウェブサイト
2014	n/a	Scott Montgomery	www.ahi.tech

Advanced Health Intelligence Ltd 基礎のまとめ

Advanced Health Intelligence の収益と売上を時価総額と比較するとどうか。
AHI 基礎統計学
時価総額	AU$22.60m
収益（TTM）	-AU$16.66m
売上高(TTM)	n/a

-24.4x

P/Sレシオ

-1.4x

PER（株価収益率

AHI は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
AHI 損益計算書（TTM）
収益	-AU$924.86k
売上原価	AU$7.14m
売上総利益	-AU$8.07m
その他の費用	AU$8.59m
収益	-AU$16.66m

直近の収益報告

Dec 31, 2023

次回決算日

該当なし

一株当たり利益（EPS）	-0.068
グロス・マージン	872.18%
純利益率	1,800.92%
有利子負債／自己資本比率	-105.6%

AHI の長期的なパフォーマンスは？

過去の実績と比較を見る

AHI 株式概要

報酬

リスク分析

Advanced Health Intelligence Ltd 競合他社

ASX:BB1

AU$25.3m

ASX:ENL

AU$18.6m

ASX:AYA

AU$18.9m

ASX:TRI

AU$10.7m

価格と性能

最新ニュース

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Recent updates

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

New major risk - Share price stability

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

Does Advanced Human Imaging (ASX:AHI) Have A Healthy Balance Sheet?

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

Advanced Human Imaging (ASX:AHI) Has Debt But No Earnings; Should You Worry?

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

What We Learned About MyFiziq's (ASX:MYQ) CEO Compensation

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

How Many MyFiziq Limited (ASX:MYQ) Shares Have Insiders Sold, In The Last Year?

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

Do Insiders Own Lots Of Shares In MyFiziq Limited (ASX:MYQ)?

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee